Skip to main content
Year archive

ONCIMMUNE HOLDINGS PLC — 2022 filings

All 47 regulatory filings released by ONCIMMUNE HOLDINGS PLC (ONC) in 2022, sourced directly from the official regulator.

47 Filings
2022 Period
2022 filings (47)
Filing Released Lang
ImmunoINSIGHTS Trading Update
Regulatory Filings
2022-12-20 English
Director/PDMR Shareholding
Director's Dealing
2022-12-19 English
Result of Capital Raising
Capital/Financing Update
2022-12-14 English
Extension of Capital Raising
Capital/Financing Update
2022-12-09 English
Proposed Placing and Subscription
Capital/Financing Update
2022-12-07 English
Grant of Options and PDMR Dealing
Regulatory Filings
2022-11-04 English
PDMR Dealing
Director's Dealing
2022-09-21 English
Unaudited results for the 12 months to 31 May 2022
Earnings Release FY 2022
2022-09-21 English
Revised Notice of Results
Report Publication Announcement
2022-08-30 English
Holding(s) in Company
Major Shareholding Notification
2022-08-15 English
Holding(s) in Company
Major Shareholding Notification
2022-08-08 English
Holding(s) in Company
Major Shareholding Notification
2022-07-15 English
Grant of Options and PDMR Dealing
Remuneration Information
2022-07-13 English
Board Changes and Trading Update
Board/Management Information
2022-07-08 English
Holding(s) in Company
Major Shareholding Notification
2022-06-20 English
Holding(s) in Company
Major Shareholding Notification
2022-06-16 English
Holding(s) in Company
Major Shareholding Notification
2022-06-07 English
Holding(s) in Company
Major Shareholding Notification
2022-06-06 English
Holding(s) in Company
Major Shareholding Notification
2022-06-01 English
Holding(s) in Company
Major Shareholding Notification
2022-05-31 English
Holding(s) in Company
Major Shareholding Notification
2022-05-26 English
Holding(s) in Company
Major Shareholding Notification
2022-05-23 English
Holding(s) in Company
Major Shareholding Notification
2022-05-20 English
Holding(s) in Company
Major Shareholding Notification
2022-05-18 English
Holding(s) in Company
Major Shareholding Notification
2022-05-05 English
Holding(s) in Company
Major Shareholding Notification
2022-05-03 English
Holding(s) in Company
Major Shareholding Notification
2022-04-26 English
Queen’s Award for Enterprise in Innovation 2022
Environmental & Social Information
2022-04-21 English
Exercise of Options, PDMR Dealing and TVR
Declaration of Voting Results & Voting Rights Announcements
2022-04-14 English
Two further ImmunoINSIGHTS contracts signed
Regulatory Filings
2022-04-08 English
Holding(s) in Company
Major Shareholding Notification
2022-04-04 English
Exercise of Options, PDMR Dealing and TVR
Director's Dealing
2022-03-29 English
Holding(s) in Company
Major Shareholding Notification
2022-03-18 English
Block Listing Six Monthly Return
Share Issue/Capital Change
2022-03-16 English
Exercise of Warrants and Total Voting Rights
Share Issue/Capital Change
2022-03-15 English
Holding(s) in Company
Major Shareholding Notification
2022-03-09 English
PDMR Dealing
Director's Dealing
2022-03-07 English
Follow-on contract to validate previous profiling
Regulatory Filings
2022-03-07 English
ImmunoINSIGHTS contract signed with global pharma
Regulatory Filings
2022-03-04 English
ImmunoINSIGHTS and Synexa partnership
Regulatory Filings
2022-03-01 English
Interim Results
Interim / Quarterly Report H1 2022
2022-02-28 English
Contract signed with Verily Life Sciences
Regulatory Filings
2022-02-28 English
[change-account-reference-date-company-current-extended] made_up_date=2022-05-31, new_date=2022-08-31
Regulatory Filings
2022-02-28 English
Notice of Half Year Results
Report Publication Announcement
2022-02-25 English
Holding(s) in Company
Major Shareholding Notification
2022-02-21 English
EarlyCDT Lung approved and adopted in Aragon Spain
Regulatory Filings
2022-02-17 English
ImmunoINSIGHTS commercial update
Regulatory Filings
2022-02-15 English